XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share - Reconciliation Between Basic and Diluted Earnings per Share (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 29, 2023
Jul. 30, 2022
Jul. 29, 2023
Jul. 30, 2022
Numerator:        
Net Income (Loss) $ 48,570 $ (42,466) $ 67,022 $ (10,726)
Add: Interest expense, net of tax, related to the 2025 Notes [1]     58  
Numerator for diluted EPS $ 48,570 $ (42,466) $ 67,080 $ (10,726)
Denominator:        
Denominator for basic EPS - weighted average shares 195,329 180,189 195,214 174,544
Add: Dilutive effect of the 2025 Notes [1],[2]     417  
Add: Dilutive effect of stock options and non-vested restricted stock [3] 774   1,191  
Denominator for diluted EPS - adjusted weighted average shares 196,103 180,189 196,822 174,544
Anti-dilutive shares [4] 509 29,221 397 38,763
[1] During the 26 weeks ended July 30, 2022, the Company adopted ASU 2020-06. The Company utilizes the "if-converted" method of calculated diluted EPS. Refer to Note 2 to the Consolidated Financial Statements for additional information regarding the impact of the adoption of ASU 2020-06.
[2] For the 13 and 26 weeks ended July 30, 2022, there were 25.3 million and 36.8 million potentially dilutive shares from the Company's 2025 Notes, respectively, that were excluded from the dilutive earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive.
[3] For the 13 and 26 weeks ended July 30, 2022, there were 3.9 million and 1.9 million potentially dilutive equity awards, respectively, that were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive.
[4] For both periods presented, anti-dilutive shares relate to stock options and unvested restricted stock.